None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Healthy males aged 30 to 60 years-old. 2) Participants whose BMI is under 30. 3) Participants who have received sufficient explanation about the purpose and content of the examination, have the ability to consent, have a good understanding, volunteered to participate and agreed to participate in the examination in writing.
Exclusion criteria
Exclusion criteria: Participants (who or who are) 1) with sleep disorders or chronic insomnia. 2) obese, have hyperlipidemia, or are using medications that may affect lipid metabolism. 3) with a history or current condition of thyroid dysfunction. 4) contract, are under treatment for or have a history of serious diseases (e.g., liver, kidney, digestive, heart, respiratory and endocrine diseases, and other metabolic disorders). 5) with a current history of ENT (ear, nose, and throat) conditions, or those unable to breathe through the nose due to other illnesses. 6) under treatment for or have a history of drug addiction and/or alcoholism. 7) whose weight has fluctuated significantly (plus or minus 5kg or more) within the past year. 8) has a routine of intense exercise. 9) have a history and/or a surgical history of digestive disease affecting digestion and absorption. 10) can't stop using supplements and/or functional foods during the study periods. 11) have declared allergic reaction to ingredients of test food. 12) whose lifestyle habits and daily routines vary frequently. 13) on specific dietary restrictions or a diet, such as fasting, extreme low-carb diets, or veganism. 14) can't stop drinking from 2 days before each measurement. 15) have excessive alcohol intake more than approximately 20 g/day of pure alcohol equivalent for four or more days a week. 16) smokers. 17) shift worker or midnight worker. 18) judged as unsuitable for the study as a research participant by the principal investigator during the screening examination. 19) have donated over 200 mL of blood and/or blood components within the last 1 month, or over 400 mL of blood and/or blood components within the last 3 months of obtaining consent. 20) planning to participate and/or had participated in other clinical studies. 21) judged as unsuitable for the current study by the principal investigator for other reasons.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fat oxidation at rest after 8 weeks of intake | — |
Secondary
| Measure | Time frame |
|---|---|
| Other Respiratory gas analysis values at rest after 8 weeks of intake | — |
Countries
Japan
Contacts
KSO Corporation Clinical Trial Management department